SPA
ORGO icon

Sherbrooke Park Advisers’s Organogenesis Holdings ORGO Stock Holding History

Sherbrooke Park Advisers’s Portfolio ORGO Stock Details ORGO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-46,238
Closed -$189K – 957
2023
Q4 		$189K Buy
+46,238
New +$129K 0.09% 342

Other funds holding ORGO

Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Sherbrooke Park Advisers's ORGO Position: Q1 2024 in Review

Sherbrooke Park Advisers sold out of Organogenesis Holdings (ORGO) in Q1 2024, closing a stake of 46,238 shares — an estimated $189K sold.

Sherbrooke Park Advisers first reported a position in ORGO in Q4 2023 and held it in 1 quarter. The position peaked at $189K in Q4 2023. 124 funds tracked by Wall St. Rank hold ORGO as of Q1 2024.

  • Sherbrooke Park Advisers reported no remaining Organogenesis Holdings position as of Q1 2024 after selling out during the quarter.
  • Sherbrooke Park Advisers sold 46,238 Organogenesis Holdings shares in Q1 2024, an estimated $189K.
  • Sherbrooke Park Advisers first reported a position in Organogenesis Holdings in Q4 2023 and held it in 1 quarter.
  • Sherbrooke Park Advisers's Organogenesis Holdings position peaked at $189K in Q4 2023.
  • 124 funds tracked by Wall St. Rank held Organogenesis Holdings as of Q1 2024.

Based on Sherbrooke Park Advisers's 13F filing for Q1 2024, filed 15 May 2024.